Center for Multiple Myeloma Nanotherapy (CMMN)


Scientists receive $13.7 million to develop new multiple myeloma treatments

School of Medicine researchers have been awarded $13.7 million from the National Cancer Institute to create new therapies for multiple myeloma, a cancer of the immune system. Samuel Achilefu, PhD, and Gregory Lanza, MD, PhD, will lead the newly created Center for Multiple Myeloma Nanotherapy, where scientists will work to develop nanomaterials and drugs to treat the disease.

Read more online in the Record.